World's Best Scientists 2026 revealed!
Award Badge
Immunology
Israel
2026
Award Badge
Medicine
Israel
2026

D-Index & Metrics

Immunology

D-Index
114
Citations
43996
World Ranking
415
National Ranking
4

Medicine

D-Index
114
Citations
44205
World Ranking
4777
National Ranking
9

Research.com Recognitions

  • 2026 - Research.com Immunology in Israel Leader Award
  • 2026 - Research.com Medicine in Israel Leader Award
  • 2025 - Research.com Immunology in Israel Leader Award
  • 2025 - Research.com Medicine in Israel Leader Award
  • 2023 - Research.com Immunology in Israel Leader Award
  • 2023 - Research.com Medicine in Israel Leader Award
  • 2022 - Research.com Immunology in Israel Leader Award
  • 2022 - Research.com Medicine in Israel Leader Award
  • 2019 - European Society for Clinical Microbiology and Infectious Diseases Excellence Award

Overview

Ron Dagan is affiliated with Ben-Gurion University of the Negev in Israel and has a research focus primarily in the field of Medicine with an emphasis on Epidemiology, Microbiology, Pulmonary and Respiratory Medicine, Infectious Diseases, and Immunology.

Their recent publications include:

  • "Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants" (2023) published in New England Journal of Medicine
  • "Decline in Pneumococcal Disease in Young Children During the Coronavirus Disease 2019 (COVID-19) Pandemic in Israel Associated With Suppression of Seasonal Respiratory Viruses, Despite Persistent Pneumococcal Carriage: A Prospective Cohort Study" (2021) published in Clinical Infectious Diseases
  • "Global Perspectives on Immunization During Pregnancy and Priorities for Future Research and Development: An International Consensus Statement" (2020) published in Frontiers in Immunology
  • "The COVID-19 pandemic as an opportunity for unravelling the causative association between respiratory viruses and pneumococcus-associated disease in young children: a prospective study" (2023) published in EBioMedicine
  • "A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE)" (2021) published in Vaccine

The main topics covered by their work are:

  • Pneumonia and Respiratory Infections
  • Respiratory viral infections research
  • Bacterial Infections and Vaccines
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Influenza Virus Research Studies
  • Immunodeficiency and Autoimmune Disorders
  • Nuclear reactor physics and engineering

Frequent co-authors include:

  • Shalom Ben-Shimol
  • Noga Givon-Lavi
  • Luwy Musey
  • Bart Adriaan van der Beek
  • David Greenberg

Common publication venues for Ron Dagan's work are:

  • Clinical Infectious Diseases
  • Vaccine
  • Open Forum Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • SSRN Electronic Journal

Ron Dagan's research mainly concentrates on infectious diseases, particularly relating to respiratory infections and immunization strategies. The work includes clinical trials and epidemiological studies on pneumococcal diseases and respiratory viruses, reflecting a detailed focus on prevention and immunogenic responses within vulnerable populations such as young children and older adults.

Among the distinctions, Ron Dagan received the European Society for Clinical Microbiology and Infectious Diseases Excellence Award in 2019.

Best Publications

  • The fundamental link between pneumococcal carriage and disease

    Birgit Simell;Kari Auranen;Helena Käyhty;David Goldblatt

  • Evaluation and Improvement of Real-Time PCR Assays Targeting lytA, ply, and psaA Genes for Detection of Pneumococcal DNA

    Maria da Gloria S. Carvalho;Maria Lucia Tondella;Karen McCaustland;Luciana Weidlich

  • Febrile infants at low risk for serious bacterial infection - An appraisal of the Rochester criteria and implications for management

    Jaskiewicz Ja;McCarthy Ca;Richardson Ac;White Kc

  • Reduction of Nasopharyngeal Carriage of Pneumococci during the Second Year of Life by a Heptavalent Conjugate Pneumococcal Vaccine

    Ron Dagan;Rimma Melamed;Marie Muallem;Lolita Piglansky

  • Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.

    Ron Dagan;Noga Givon-Lavi;Orly Zamir;Merav Sikuler-Cohen

  • Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis.

    Ron Dagan;Keith R. Powell;Caroline B. Hall;Marilyn A. Menegus

  • Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants.

    Luis Jódar;Jay Butler;George Carlone;Ron Dagan

  • Association of Serotype with Risk of Death Due to Pneumococcal Pneumonia: A Meta-Analysis

    Daniel M. Weinberger;Zitta B. Harboe;Elisabeth A. M. Sanders;Moses Ndiritu

  • Otitis media and its consequences: beyond the earache

    Anne Vergison;Ron Dagan;Adriano Arguedas;Jan Bonhoeffer

  • Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children.

    Gili Regev-Yochay;Ron Dagan;Meir Raz;Yehuda Carmeli

  • Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings.

    Gili Regev-Yochay;Gili Regev-Yochay;Meir Raz;Ron Dagan;Nurith Porat

  • Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants

    Ron Dagan;Juhani Eskola;Claude Leclerc;Odile Leroy

  • Glycoconjugate vaccines and immune interference: A review

    Ron Dagan;Jan Poolman;Claire-Anne Siegrist

  • Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies.

    David H. Sniadack;Benjamin Schwartz;Harvey Lipman;J. Bogaerts

  • Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy

    Ron Dagan;Keith P. Klugman;William A. Craig;Fernando Baquero

  • Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis.

    John E. Adamou;Jon H. Heinrichs;Alice L. Erwin;William Walsh

  • Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.

    Dror Mevorach;Emilia Anis;Noa Cedar;Michal Bromberg

  • Impact of conjugate pneumococcal vaccines on antibiotic resistance.

    Ron Dagan;Keith P Klugman;Keith P Klugman

  • Incidence of hepatitis a in Israel following universal immunization of toddlers

    Ron Dagan;Alex Leventhal;Emilia Anis;Paul Slater

  • Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial

    Ron Dagan;Scott Patterson;Christine Juergens;David Greenberg

  • Otitis media and its consequences: beyond the earache

    Anne Vergison;Ron Dagan;Adriano Arguedas;Jan Bonhoeffer

  • The fundamental link between pneumococcal carriage and disease

    Birgit Simell;Kari Auranen;Helena Kayhty;David Goldblatt

Frequent Co-Authors

Noga Givon-Lavi
Noga Givon-Lavi Ben-Gurion University of the Negev
David Greenberg
David Greenberg Ben-Gurion University of the Negev
Eugene Leibovitz
Eugene Leibovitz Ben-Gurion University of the Negev
Pablo Yagupsky
Pablo Yagupsky Ben-Gurion University of the Negev
Keith P. Klugman
Keith P. Klugman Bill & Melinda Gates Foundation
Michael R. Jacobs
Michael R. Jacobs University Hospitals of Cleveland
Helena Käyhty
Helena Käyhty Finnish Institute for Health and Welfare (THL)
Shabir A. Madhi
Shabir A. Madhi University of the Witwatersrand
Marc Lipsitch
Marc Lipsitch Harvard University
Ethan Rubinstein
Ethan Rubinstein University of Manitoba

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open up diverse career pathways in healthcare and research. Many students transition into nursing roles to build a strong clinical foundation. Programs like accelerated fnp programs offer a fast track to becoming Family Nurse Practitioners, blending advanced clinical skills with immunological knowledge.

Individuals without a nursing background can also enter the field through online nursing programs for non nurses. These programs provide flexible pathways to gain essential nursing credentials while applying immunology concepts in patient care.

For those just starting their nursing education, absn programs with high acceptance rates present accessible options to quickly earn a Bachelor of Science in Nursing, crucial for advanced immunology-related roles. Similarly, starting with which lpn programs are easiest to get into can be a stepping stone toward more specialized immunology careers in clinical settings.

Choosing the right online degree or certificate program aligned with immunology can significantly impact career growth, offering practical experience and theoretical expertise in this rapidly evolving field.

Best Scientists Citing Ron Dagan

Trending Scientists